Style | Citing Format |
---|---|
MLA | Hasanzad M, et al.. "Artificial Intelligence Perspective in the Future of Endocrine Diseases." Journal of Diabetes and Metabolic Disorders, vol. 21, no. 1, 2022, pp. 971-978. |
APA | Hasanzad M, Aghaei Meybodi HR, Sarhangi N, Larijani B (2022). Artificial Intelligence Perspective in the Future of Endocrine Diseases. Journal of Diabetes and Metabolic Disorders, 21(1), 971-978. |
Chicago | Hasanzad M, Aghaei Meybodi HR, Sarhangi N, Larijani B. "Artificial Intelligence Perspective in the Future of Endocrine Diseases." Journal of Diabetes and Metabolic Disorders 21, no. 1 (2022): 971-978. |
Harvard | Hasanzad M et al. (2022) 'Artificial Intelligence Perspective in the Future of Endocrine Diseases', Journal of Diabetes and Metabolic Disorders, 21(1), pp. 971-978. |
Vancouver | Hasanzad M, Aghaei Meybodi HR, Sarhangi N, Larijani B. Artificial Intelligence Perspective in the Future of Endocrine Diseases. Journal of Diabetes and Metabolic Disorders. 2022;21(1):971-978. |
BibTex | @article{ author = {Hasanzad M and Aghaei Meybodi HR and Sarhangi N and Larijani B}, title = {Artificial Intelligence Perspective in the Future of Endocrine Diseases}, journal = {Journal of Diabetes and Metabolic Disorders}, volume = {21}, number = {1}, pages = {971-978}, year = {2022} } |
RIS | TY - JOUR AU - Hasanzad M AU - Aghaei Meybodi HR AU - Sarhangi N AU - Larijani B TI - Artificial Intelligence Perspective in the Future of Endocrine Diseases JO - Journal of Diabetes and Metabolic Disorders VL - 21 IS - 1 SP - 971 EP - 978 PY - 2022 ER - |